A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 16490876)

Published in Arch Otolaryngol Head Neck Surg on February 01, 2006

Authors

Pär Stjärne1, Ralph Mösges, Mark Jorissen, Desiderio Passàli, Luisa Bellussi, Heribert Staudinger, Melvyn Danzig

Author Affiliations

1: Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden. par.stjarne@karolinska.se

Articles citing this

Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc (2011) 1.36

Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin Immunol (2011) 1.30

A review of nasal polyposis. Ther Clin Risk Manag (2008) 1.05

Canadian guidelines for chronic rhinosinusitis: Clinical summary. Can Fam Physician (2013) 1.01

Sinus surgery and delivery method influence the effectiveness of topical corticosteroids for chronic rhinosinusitis: systematic review and meta-analysis. Am J Rhinol Allergy (2013) 0.91

Pathophysiology of nasal congestion. Int J Gen Med (2010) 0.86

Treatment of congestion in upper respiratory diseases. Int J Gen Med (2010) 0.84

Chronic rhinosinusitis and emerging treatment options. Int J Gen Med (2013) 0.81

Comparison of the effect of endoscopic sinus surgery versus medical therapy on olfaction in nasal polyposis. Eur Arch Otorhinolaryngol (2013) 0.81

Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis. Eur Arch Otorhinolaryngol (2010) 0.77

Effects of intranasal steroid treatment on the presence of biofilms in non-allergic patients with chronic rhinosinusitis with nasal polyposis. Eur Arch Otorhinolaryngol (2013) 0.77

Mometasone furoate nasal spray: a systematic review. Multidiscip Respir Med (2016) 0.75

Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA(2)LEN study. Clin Transl Allergy (2017) 0.75

Articles by these authors

Preoperative symptoms of body dysmorphic disorder determine postoperative satisfaction and quality of life in aesthetic rhinoplasty. Plast Reconstr Surg (2013) 2.71

European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl (2010) 2.59

Mutations in the DNAH11 (axonemal heavy chain dynein type 11) gene cause one form of situs inversus totalis and most likely primary ciliary dyskinesia. Proc Natl Acad Sci U S A (2002) 2.21

CCDC39 is required for assembly of inner dynein arms and the dynein regulatory complex and for normal ciliary motility in humans and dogs. Nat Genet (2010) 2.12

Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol (2005) 1.81

Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol (2006) 1.80

CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2015) 1.70

European position paper on the anatomical terminology of the internal nose and paranasal sinuses. Rhinol Suppl (2014) 1.63

High prevalence of body dysmorphic disorder symptoms in patients seeking rhinoplasty. Plast Reconstr Surg (2011) 1.58

Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study. BMC Pulm Med (2010) 1.55

The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. Laryngoscope (2009) 1.46

European and Mexican vs US diagnostic extracts of Bermuda grass and cat in skin testing. Ann Allergy Asthma Immunol (2011) 1.41

Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol (2006) 1.38

The use of handheld computers in clinical trials. Control Clin Trials (2002) 1.32

Mutations in CCDC39 and CCDC40 are the major cause of primary ciliary dyskinesia with axonemal disorganization and absent inner dynein arms. Hum Mutat (2013) 1.31

Malignancies of the nasal cavity and paranasal sinuses: long-term outcome with conventional or three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.19

Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.19

Treatment of inferior turbinate hypertrophy: a randomized clinical trial. Ann Otol Rhinol Laryngol (2003) 1.15

Primary ciliary dyskinesia, an orphan disease. Eur J Pediatr (2012) 1.14

Is the sensitivity of primary ciliary dyskinesia detection by ciliary function analysis 100%? Eur Respir J (2013) 1.09

Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma. J Asthma (2011) 1.05

Acute otitis media: From diagnosis to prevention. Summary of the Italian guideline. Int J Pediatr Otorhinolaryngol (2010) 1.03

Primary ciliary dyskinesia: critical evaluation of clinical symptoms and diagnosis in patients with normal and abnormal ultrastructure. Orphanet J Rare Dis (2014) 1.03

Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients. Otol Neurotol (2007) 1.01

Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study. Allergy Asthma Proc (2015) 0.98

Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol (2005) 0.96

Atomized nasal douche vs nasal lavage in acute viral rhinitis. Arch Otolaryngol Head Neck Surg (2005) 0.94

Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent acute otitis media and chronic otitis media with effusion: implications for management. Pediatr Infect Dis J (2003) 0.94

Ciliary beating recovery in deficient human airway epithelial cells after lentivirus ex vivo gene therapy. PLoS Genet (2009) 0.93

Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy (2012) 0.93

The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis: a 3-year prospective observational study. Am J Rhinol Allergy (2014) 0.93

Foreign Bodies in the Oesophagus: The Experience of the Buenos Aires Paediatric ORL Clinic. Int J Pediatr (2010) 0.92

Mediators of inflammation in the early and the late phase of allergic rhinitis. Curr Opin Allergy Clin Immunol (2004) 0.92

Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol (2003) 0.90

Safety of desloratadine syrup in children. Curr Med Res Opin (2004) 0.90

Localization of candidate regions for a novel gene for Kartagener syndrome. Eur J Hum Genet (2006) 0.89

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease. Respir Res (2008) 0.89

Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials. Int J Chron Obstruct Pulmon Dis (2012) 0.89

Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD. Int J Chron Obstruct Pulmon Dis (2012) 0.89

Screening tools for body dysmorphic disorder in a cosmetic surgery setting. Laryngoscope (2011) 0.86

Series of extranodal natural killer/T-cell lymphoma, nasal type, with periorbital involvement. Orbit (2014) 0.86

A prospective, controlled study of SNS01 (ectoine nasal spray) compared to BNO-101 (phytotherapeutic dragées) in patients with acute rhinosinusitis. Curr Med Res Opin (2013) 0.86

Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination. J Asthma (2011) 0.86

Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids. Curr Med Res Opin (2005) 0.86

High-speed digital imaging method for ciliary beat frequency measurement. J Pharm Pharmacol (2005) 0.86

Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD. Respir Med (2011) 0.86

Treatment of recurrent chronic hyperplastic sinusitis with nasal polyposis. Arch Otolaryngol Head Neck Surg (2003) 0.85

Prevalence and determinants of allergic diseases in a Congolese population. Int Forum Allergy Rhinol (2012) 0.85

Structural and immunological characteristics of chronically inflamed adenotonsillar tissue in childhood. Clin Diagn Lab Immunol (2004) 0.85

Diagnostic accuracy of nitric oxide measurements to detect primary ciliary dyskinesia. Eur J Clin Invest (2014) 0.85

Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use. Expert Opin Drug Saf (2006) 0.84

Long-term follow-up of 44 patients with adenocarcinoma of the nasal cavity and sinuses primarily treated with endoscopic resection followed by radiotherapy. Head Neck (2010) 0.84

Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma. BMC Pediatr (2009) 0.83

Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma. Ann Pharmacother (2005) 0.83

Toys in the upper aerodigestive tract: new evidence on their risk as emerging from the Susy Safe Study. Int J Pediatr Otorhinolaryngol (2012) 0.83

A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber. Ann Allergy Asthma Immunol (2009) 0.83

Nasal foreign bodies: the experience of the Buenos Aires pediatric otolaryngology clinic. Pediatr Int (2011) 0.83

IL-10- and IL-12-independent down-regulation of allergic sensitization by stimulation of CD40 signaling. J Immunol (2006) 0.82

Safety aspects of Cluster immunotherapy with semi-depot allergen extracts in seasonal allergic rhinoconjunctivitis. Eur Arch Otorhinolaryngol (2010) 0.82

In the (sub)tropics allergic rhinitis and its impact on asthma classification of allergic rhinitis is more useful than perennial-seasonal classification. Am J Rhinol Allergy (2014) 0.81

A systematic review of RCTs with nucleoplasty - an update. Pain Physician (2013) 0.81

Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit. Allergy Asthma Proc (2009) 0.81

Dosing of European sublingual immunotherapy maintenance solutions relative to monthly recommended dosing of subcutaneous immunotherapy. Allergy Asthma Proc (2016) 0.81

International study of the incidence of particular types of septal deformities in chronic rhinosinusitis patients: the outcomes from five countries. Am J Rhinol Allergy (2014) 0.81

Over diagnosis of persistent allergic rhinitis in perennial allergic rhinitis patients: a nationwide study in Mexico. Am J Rhinol Allergy (2013) 0.81

Nuts and seed: a natural yet dangerous foreign body. Int J Pediatr Otorhinolaryngol (2012) 0.80

In vitro polarized transport of L-phenylalanine in human nasal epithelium and partial characterization of the amino acid transporters involved. Pharm Res (2003) 0.80

Nasal corticosteroid treatment reduces substance P levels in tear fluid in allergic rhinoconjunctivitis. Ann Allergy Asthma Immunol (2012) 0.80

Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis. Chest (2009) 0.80

Recent advances in otitis media. 8. Diagnosis and screening. Ann Otol Rhinol Laryngol Suppl (2002) 0.79

Alterations in rhinosinusal homeostasis in a sportive population: our experience with 106 athletes. Eur Arch Otorhinolaryngol (2003) 0.79

Open versus robotic thyroidectomy: is it really a controversial choice? Kulak Burun Bogaz Ihtis Derg (2015) 0.79

Sublingual immunotherapy in daily medical practice: effectiveness of different treatment schedules - IPD meta-analysis. Curr Med Res Opin (2010) 0.79

Toys in the upper aerodigestive tract: evidence on their risk as emerging from the ESFBI study. Auris Nasus Larynx (2011) 0.79

Retrospective study on Romanian foreign bodies injuries in children. Int J Pediatr Otorhinolaryngol (2012) 0.79

Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses. Radiother Oncol (2007) 0.79

Beneficial effect of antibiotics on ciliary beat frequency of human nasal epithelial cells exposed to bacterial toxins. J Pharm Pharmacol (2008) 0.78

Nasal saline irrigations for the symptoms of acute and chronic rhinosinusitis. Curr Allergy Asthma Rep (2013) 0.78

Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium. Int J Pharm (2002) 0.78

Rheopheresis for sudden sensorineural hearing loss. Atheroscler Suppl (2009) 0.78

Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit. Ann Allergy Asthma Immunol (2009) 0.78

Activity of coenzyme Q 10 (Q-Ter multicomposite) on recovery time in noise-induced hearing loss. Noise Health (2014) 0.78

Short-time cold dry air exposure: a useful diagnostic tool for nasal hyperresponsiveness. Laryngoscope (2012) 0.78

Results of endoscopic resection followed by radiotherapy for primarily diagnosed adenocarcinomas of the paranasal sinuses. Head Neck (2008) 0.78

Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis. Laryngoscope (2010) 0.78

How to improve current therapeutic standards in upper respiratory infections: value of fusafungine. Curr Med Res Opin (2004) 0.78

Oralair(®): a causal treatment for grass pollen-induced allergic rhinoconjunctivitis. Immunotherapy (2013) 0.78

Mechanistic appraisal of the effects of some protease inhibitors on ciliary beat frequency in a sequential cell culture system of human nasal epithelium. Eur J Pharm Biopharm (2003) 0.78

Stationery injuries in the upper aerodigestive system: results from the Susy Safe Project. Int J Pediatr Otorhinolaryngol (2012) 0.78

The RHINASTHMA GAV scores without SLIT, at the beginning and at the end of seasonal SLIT. Asian Pac J Allergy Immunol (2010) 0.78

Efficacy of a topical suspension of bacterial antigens for the management of recurrent eczema in children. Med Sci Monit (2004) 0.77

Foreign bodies injuries in children: analysis of Thailand data. Int J Pediatr Otorhinolaryngol (2012) 0.77

Rhinoplasty from a rhinologist's perspective: need for recognition of associated sinonasal conditions. Am J Rhinol Allergy (2012) 0.77

Specific aminopeptidases of excised human nasal epithelium and primary culture: a comparison of functional characteristics and gene transcripts expression. J Pharm Pharmacol (2009) 0.77

Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma. Ann Allergy Asthma Immunol (2006) 0.77

Skin prick test evaluation of Dermatophagoides pteronyssinus diagnostic extracts from Europe, Mexico, and the United States. Ann Allergy Asthma Immunol (2010) 0.77

Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis. Allergy Asthma Proc (2006) 0.77